silybin has been researched along with Bone Loss, Osteoclastic in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gong, JH; Han, SJ; Kang, MK; Kang, SW; Kang, YH; Kim, JL; Lee, ES | 1 |
Gong, JH; Han, SY; Kang, MK; Kang, YH; Kim, JL; Park, SH | 1 |
2 other study(ies) available for silybin and Bone Loss, Osteoclastic
Article | Year |
---|---|
Osteoblastogenesis and osteoprotection enhanced by flavonolignan silibinin in osteoblasts and osteoclasts.
Topics: Acid Phosphatase; Alkaline Phosphatase; Animals; Bone Morphogenetic Protein 2; Bone Resorption; Calcium; Cathepsin K; Cell Differentiation; Cell Line; Cell Proliferation; Collagen Type I; Connective Tissue Growth Factor; Isoenzymes; Macrophages; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Mice; Osteoblasts; Osteoclasts; Osteogenesis; Plant Extracts; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; Silybin; Silymarin; Tartrate-Resistant Acid Phosphatase; TNF Receptor-Associated Factor 6 | 2012 |
Novel antiosteoclastogenic activity of phloretin antagonizing RANKL-induced osteoclast differentiation of murine macrophages.
Topics: Acid Phosphatase; Animals; Bone Resorption; Carbonic Anhydrases; Cathepsin K; Cell Differentiation; Cells, Cultured; Dose-Response Relationship, Drug; Isoenzymes; Macrophages; Matrix Metalloproteinase 9; Mice; NF-kappa B; NFATC Transcription Factors; Osteoclasts; Phloretin; RANK Ligand; Silybin; Silymarin; Tartrate-Resistant Acid Phosphatase; TNF Receptor-Associated Factor 6; Vacuolar Proton-Translocating ATPases | 2012 |